Nymox Pharmaceutical
NYMX
#10184
Rank
ยฃ13.64 M
Marketcap
Country
ยฃ0.15
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -ยฃ1.83 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -ยฃ4.89 Million, an increase over its 2021 earnings that were of -ยฃ9.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -ยฃ1.83 Million-62.58%
2022 -ยฃ4.89 Million-47.71%
2021 -ยฃ9.34 Million6.61%
2020 -ยฃ8.76 Million-10.91%
2019 -ยฃ9.83 Million24.24%
2018 -ยฃ7.91 Million-20.03%
2017 -ยฃ9.89 Million2.71%
2016 -ยฃ9.63 Million-63.86%
2015 -ยฃ26.65 Million674.44%
2014 -ยฃ3.45 Million-6.11%
2013 -ยฃ3.67 Million-35.66%
2012 -ยฃ5.7 Million-20.76%
2011 -ยฃ7.19 Million38.33%
2010 -ยฃ5.2 Million35.59%
2009 -ยฃ3.84 Million11.8%
2008 -ยฃ3.43 Million-12.94%
2007 -ยฃ3.94 Million8.85%
2006 -ยฃ3.62 Million36.5%
2005 -ยฃ2.66 Million-4.4%
2004 -ยฃ2.78 Million-14.58%
2003 -ยฃ3.25 Million
2001 -ยฃ2.39 Million-20.54%
2000 -ยฃ3 Million21.72%
1999 -ยฃ2.47 Million-25.56%
1998 -ยฃ3.31 Million101.3%
1997 -ยฃ1.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
ยฃ6.08 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.86 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ0.96 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.82 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.22 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA